Trader consensus around a 91% chance that no new COVID variant of concern emerges before 2027 reflects the current absence of any SARS-CoV-2 lineage meeting WHO or ECDC VOC criteria. As of mid-2026, dominant strains such as XFG and NB.1.8.1 remain Omicron descendants with limited impact on severity or immunity, while the divergent BA.3.2 lineage has been tracked as a variant under monitoring without evidence of elevated risk. Ongoing genomic surveillance, combined with broad population immunity from prior infections and updated vaccines, has slowed the conditions needed for a new designation. A sudden, highly mutated strain with major immune escape and increased virulence could still shift probabilities within the remaining months of 2026.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoSim
$243,750 Vol.
$243,750 Vol.
31 dez 2026
Sim
$243,750 Vol.
$243,750 Vol.
31 dez 2026
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.Trader consensus around a 91% chance that no new COVID variant of concern emerges before 2027 reflects the current absence of any SARS-CoV-2 lineage meeting WHO or ECDC VOC criteria. As of mid-2026, dominant strains such as XFG and NB.1.8.1 remain Omicron descendants with limited impact on severity or immunity, while the divergent BA.3.2 lineage has been tracked as a variant under monitoring without evidence of elevated risk. Ongoing genomic surveillance, combined with broad population immunity from prior infections and updated vaccines, has slowed the conditions needed for a new designation. A sudden, highly mutated strain with major immune escape and increased virulence could still shift probabilities within the remaining months of 2026.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Mercado Aberto: Dec 1, 2025, 4:49 PM ET
Volume
$243,750Data de Término
31 dez 2026Mercado Aberto
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.Trader consensus around a 91% chance that no new COVID variant of concern emerges before 2027 reflects the current absence of any SARS-CoV-2 lineage meeting WHO or ECDC VOC criteria. As of mid-2026, dominant strains such as XFG and NB.1.8.1 remain Omicron descendants with limited impact on severity or immunity, while the divergent BA.3.2 lineage has been tracked as a variant under monitoring without evidence of elevated risk. Ongoing genomic surveillance, combined with broad population immunity from prior infections and updated vaccines, has slowed the conditions needed for a new designation. A sudden, highly mutated strain with major immune escape and increased virulence could still shift probabilities within the remaining months of 2026.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Volume
$243,750Data de Término
31 dez 2026Mercado Aberto
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...Trader consensus around a 91% chance that no new COVID variant of concern emerges before 2027 reflects the current absence of any SARS-CoV-2 lineage meeting WHO or ECDC VOC criteria. As of mid-2026, dominant strains such as XFG and NB.1.8.1 remain Omicron descendants with limited impact on severity or immunity, while the divergent BA.3.2 lineage has been tracked as a variant under monitoring without evidence of elevated risk. Ongoing genomic surveillance, combined with broad population immunity from prior infections and updated vaccines, has slowed the conditions needed for a new designation. A sudden, highly mutated strain with major immune escape and increased virulence could still shift probabilities within the remaining months of 2026.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions